HROW Q2 2023 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$33M+43.5% YoY

Gross Profit

$23M70.1% margin

Operating Income

$2M7.0% margin

Net Income

-$4M-12.6% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+28.2%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$224M

Total Liabilities

$202M

Stockholders' Equity

$22M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$23M	+43.5%
Gross Profit	$23M	$17M	+39.8%
Operating Income	$2M	$2M	+39.2%
Net Income	-$4M	-$6M	+32.2%

Revenue Segments

Other Revenues

$4M100%